Rossari Biotech share price
NSE: ROSSARIChemicalsSpecialty Chemicals
Rossari Biotech at a glance
Rossari Biotech (NSE: ROSSARI) closed at ₹421.35 on 22 Oct 2026, up 1.29% on the day. With a market capitalisation of ₹2,334 Cr, it ranks 1083rd by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Chemicals sector; its industry is Specialty Chemicals.
At its last close the stock traded at 15.7× trailing earnings, against a return on equity of 11.2% in FY26. Over the past year the share price has fallen 34.6%. Its 52-week range is ₹375.00 (30 Mar 2026) to ₹663.00 (28 Oct 2025); the last close is 36.4% below the high. Promoters held 68.14% of the company as of 30 Jun 2026.
Key numbers
- Market cap
- ₹2,334 CrRank 1083 on NSE
- P/E (trailing)
- 15.7×
- Price to book
- 1.57×FY26
- ROE
- 11.2%FY26
- ROCE
- 15.3%FY26
- Debt to equity
- 0.31FY26
- Net profit margin
- 6.1%FY26
- Book value / share
- ₹240.74FY26
- 52-week high
- ₹663.0028 Oct 2025
- 52-week low
- ₹375.0030 Mar 2026
- 1-year return
- −34.6%
- RSI (14-day)
- 42.8
Returns to 22 Oct 2026
| Period | 1 day | 1 week | 1 month | 3 months | 1 year |
|---|---|---|---|---|---|
| Price change | +1.29% | −2.5% | −4.8% | −15.2% | −34.6% |
Rossari Biotech financials
| Item | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Revenue | ₹709 Cr | ₹1,483 Cr | ₹1,656 Cr | ₹1,831 Cr | ₹2,080 Cr | ₹2,396 Cr |
| Operating profit | ₹106 Cr | ₹135 Cr | ₹143 Cr | ₹177 Cr | ₹184 Cr | ₹201 Cr |
| Net profit | ₹80 Cr | ₹96 Cr | ₹106 Cr | ₹131 Cr | ₹135 Cr | ₹147 Cr |
| EPS (₹) | ₹16.00 | ₹18.00 | ₹19.00 | ₹24.00 | ₹25.00 | ₹27.00 |
| Cash from operations | ₹48 Cr | ₹29 Cr | ₹152 Cr | ₹43 Cr | ₹137 Cr | ₹65 Cr |
| Total debt | ₹0 Cr | ₹0 Cr | ₹35 Cr | ₹33 Cr | ₹100 Cr | ₹94 Cr |
| Shareholders' equity | ₹409 Cr | ₹805 Cr | ₹915 Cr | ₹1,048 Cr | ₹1,185 Cr | ₹1,333 Cr |
Rossari Biotech shareholding pattern
| Holder | 31 Mar 2025 | 30 Jun 2025 | 30 Sep 2025 | 31 Dec 2025 | 31 Mar 2026 | 30 Jun 2026 |
|---|---|---|---|---|---|---|
| Promoters | 68.18% | 68.17% | 68.17% | 68.16% | 68.15% | 68.14% |
| Foreign institutions | 3.98% | 3.48% | 2.69% | 2.33% | 2.18% | 2.02% |
| Domestic institutions | 17.59% | 17.84% | 18.18% | 18.26% | 18.20% | 14.64% |
| Non-institutions | 10.25% | 10.51% | 10.95% | 11.26% | 11.46% | 15.20% |
Rossari Biotech vs peers
The listed Chemicals companies nearest to Rossari Biotech by market capitalisation.
| Company | Price | 1 day | 1 year | Market cap | P/E | ROE |
|---|---|---|---|---|---|---|
| BHAGCHEMBhagiradha Chemicals & Industries | ₹203.99 | −2.16% | −17.8% | ₹2,645 Cr | 187.1 | — |
| SIRCASirca Paints India | ₹429.35 | +0.72% | −14.3% | ₹2,438 Cr | 36.9 | — |
| JGCHEMJ.G.Chemicals | ₹600.70 | +2.68% | +46.0% | ₹2,354 Cr | 35.8 | — |
| ROSSARIRossari Biotech | ₹421.35 | +1.29% | −34.6% | ₹2,334 Cr | 15.7 | — |
| STALLIONStallion India Fluorochemicals | ₹192.50 | −2.73% | −37.0% | ₹2,235 Cr | 36 | — |
| GSPCROPGSP Crop Science | ₹455.15 | +0.81% | — | ₹2,117 Cr | 18.2 | — |
| INDIAGLYCOIndia Glycols | ₹305.55 | +0.02% | −67.8% | ₹2,048 Cr | 6.6 | — |
Ask anything about Rossari Biotech
Pivot answers on the live chart with evidence you can check, and tests strategies against ROSSARI's own history. Try: “Why has ROSSARI moved over the last three months?” · “Backtest a 50-day moving-average crossover on ROSSARI over five years” · “Compare ROSSARI with BHAGCHEM on margins and valuation”
Frequently asked questions about Rossari Biotech
What is the share price of Rossari Biotech today?
Rossari Biotech (NSE: ROSSARI) last closed at ₹421.35 on 22 Oct 2026. Its 52-week high is ₹663.00 and its 52-week low is ₹375.00.
What is the market cap of Rossari Biotech?
Rossari Biotech's market capitalisation is ₹2,334 Cr (₹2,334 Cr) at the 22 Oct 2026 close, ranking 1083rd among the NSE companies Pivot tracks.
What is the P/E ratio of Rossari Biotech?
Rossari Biotech trades at a trailing P/E of 15.7. The median P/E of the 6 closest Chemicals peers by market cap is 36.
What is the ROE and ROCE of Rossari Biotech?
Return on equity was 11.2% in FY26 and return on capital employed was 15.3% in FY26 (consolidated figures).
Is Rossari Biotech a debt-free company?
No. Rossari Biotech's debt-to-equity ratio was 0.31 in FY26, with total debt of ₹94 Cr.
How has Rossari Biotech stock performed over the last year?
Rossari Biotech's share price has fallen 34.6% over the past year, −15.2% over three months and −4.8% over one month, to the 22 Oct 2026 close.
What is the shareholding pattern of Rossari Biotech?
As of 30 Jun 2026: promoters 68.14%, foreign institutions 2.02%, domestic institutions 14.64%, non-institutions 15.20%.
Who are Rossari Biotech's competitors?
The listed Chemicals companies closest to Rossari Biotech by market cap are Bhagiradha Chemicals & Industries, Sirca Paints India, J.G.Chemicals, Stallion India Fluorochemicals, GSP Crop Science and India Glycols.
Is Rossari Biotech a good stock to buy?
Pivot does not give buy or sell recommendations. This page sets out Rossari Biotech's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on ROSSARI against its own history before risking money. This is analysis, not financial advice.
Sources and method
Prices: NSE daily closes to 22 Oct 2026 (returns and ratios at the 22 Oct 2026 close). Fundamentals: company filings via Moneycontrol, consolidated where available. Shareholding: exchange shareholding-pattern filings. The 52-week range uses intraday highs and lows; the chart marks closing prices. P/E is the last close over trailing twelve-month EPS. Market-cap rank is among the 4,183 NSE companies Pivot tracks; SEBI's bands call the top 100 large-cap and the next 150 mid-cap. Figures marked “—” are not available rather than zero. This is analysis, not financial advice.
More: all Chemicals stocks · companies starting with R · all NSE stocks · this page as text